# Moog Inc.: financial statements, quarterly

MOG-A · NYSE · CIK 67887 · [Industrials](/sectors/industrials.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/mog-a.md) · [Financials](/companies/mog-a/financials.md) · [Filings](/companies/mog-a/filings.md) · [Insiders](/companies/mog-a/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mog-a/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [869 d](/filings/0001628280-25-054103.md) | [855](/filings/0001628280-25-054103.md) | [920](/filings/0001628280-25-054103.md) | [914](/filings/0001628280-25-054103.md) | [919 d](/filings/0001628280-25-054103.md) | [908](/filings/0001628280-26-004327.md) | [934](/filings/0001628280-26-027064.md) | [970](/filings/0001628280-26-051294.md) | [1,049 d](/filings/0001628280-25-054103.md) | [1,100](/filings/0001628280-26-004327.md) | [1,052](/filings/0001628280-26-027064.md) | [1,117](/filings/0001628280-26-051294.md) |
| Cost of revenue | $m | [615 d](/filings/0001628280-25-054103.md) | [614](/filings/0001628280-25-054103.md) | [661](/filings/0001628280-25-054103.md) | [657](/filings/0001628280-25-054103.md) | [658 d](/filings/0001628280-25-054103.md) | [663](/filings/0001628280-26-004327.md) | [675](/filings/0001628280-26-027064.md) | [697](/filings/0001628280-26-051294.md) | [760 d](/filings/0001628280-25-054103.md) | [806](/filings/0001628280-26-004327.md) | [764](/filings/0001628280-26-027064.md) | [769](/filings/0001628280-26-051294.md) |
| Gross profit | $m | [250 d](/filings/0001628280-25-054103.md) | [241](/filings/0001628280-25-054103.md) | [259](/filings/0001628280-25-054103.md) | [256](/filings/0001628280-25-054103.md) | [256 d](/filings/0001628280-25-054103.md) | [245](/filings/0001628280-26-004327.md) | [257](/filings/0001628280-26-027064.md) | [267](/filings/0001628280-26-051294.md) | [289 d](/filings/0001628280-25-054103.md) | [294](/filings/0001628280-26-004327.md) | [288](/filings/0001628280-26-027064.md) | [347](/filings/0001628280-26-051294.md) |
| Research and development | $m | [29.4 d](/filings/0001628280-25-054103.md) | [30.6](/filings/0001628280-25-054103.md) | [28.4](/filings/0001628280-25-054103.md) | [27.8](/filings/0001628280-25-054103.md) | [26.0 d](/filings/0001628280-25-054103.md) | [23.6](/filings/0001628280-26-004327.md) | [24.5](/filings/0001628280-26-027064.md) | [21.9](/filings/0001628280-26-051294.md) | [23.7 d](/filings/0001628280-25-054103.md) | [24.6](/filings/0001628280-26-004327.md) | [26.7](/filings/0001628280-26-027064.md) | [33.0](/filings/0001628280-26-051294.md) |
| Selling, general and administrative | $m | [123 d](/filings/0001628280-25-054103.md) | [121](/filings/0001628280-25-054103.md) | [126](/filings/0001628280-25-054103.md) | [128](/filings/0001628280-25-054103.md) | [126 d](/filings/0001628280-25-054103.md) | [128](/filings/0001628280-26-004327.md) | [134](/filings/0001628280-26-027064.md) | [140](/filings/0001628280-26-051294.md) | [152 d](/filings/0001628280-25-054103.md) | [149](/filings/0001628280-26-004327.md) | [136](/filings/0001628280-26-027064.md) | [151](/filings/0001628280-26-051294.md) |
| Operating income | $m | [89.0 d](/filings/0001628280-25-054103.md) | [94.5](/filings/0000067887-25-000010.md) | [112](/filings/0000067887-25-000036.md) | [105](/filings/0000067887-25-000051.md) | [92.5 d](/filings/0001628280-25-054103.md) | [104](/filings/0001628280-26-004327.md) | [109](/filings/0001628280-26-027064.md) | [112](/filings/0001628280-26-051294.md) | [125 d](/filings/0001628280-25-054103.md) | [135](/filings/0001628280-26-004327.md) | [138](/filings/0001628280-26-027064.md) | [176](/filings/0001628280-26-051294.md) |
| Interest expense | $m | [14.5 d](/filings/0001628280-25-054103.md) | [15.1](/filings/0001628280-25-054103.md) | [16.8](/filings/0001628280-25-054103.md) | [17.0](/filings/0001628280-25-054103.md) | [17.4 d](/filings/0001628280-25-054103.md) | [16.2](/filings/0001628280-26-004327.md) | [19.5](/filings/0001628280-26-027064.md) | [17.8](/filings/0001628280-26-051294.md) | [18.5 d](/filings/0001628280-25-054103.md) | [17.2](/filings/0001628280-26-004327.md) | [15.5](/filings/0001628280-26-027064.md) | [15.8](/filings/0001628280-26-051294.md) |
| Income tax | $m | [10.8 d](/filings/0001628280-25-054103.md) | [16.3](/filings/0001628280-25-054103.md) | [17.1](/filings/0001628280-25-054103.md) | [15.4](/filings/0001628280-25-054103.md) | [12.2 d](/filings/0001628280-25-054103.md) | [16.9](/filings/0001628280-26-004327.md) | [17.4](/filings/0001628280-26-027064.md) | [17.9](/filings/0001628280-26-051294.md) | [25.4 d](/filings/0001628280-25-054103.md) | [22.4](/filings/0001628280-26-004327.md) | [27.0](/filings/0001628280-26-027064.md) | [(14.6)](/filings/0001628280-26-051294.md) |
| Net income | $m | [43.7 d](/filings/0001628280-25-054103.md) | [52.6](/filings/0001628280-25-054103.md) | [54.5](/filings/0001628280-25-054103.md) | [59.1](/filings/0001628280-25-054103.md) | [42.5 d](/filings/0001628280-25-054103.md) | [57.5](/filings/0001628280-26-004327.md) | [54.6](/filings/0001628280-26-027064.md) | [58.5](/filings/0001628280-26-051294.md) | [64.4 d](/filings/0001628280-25-054103.md) | [78.9](/filings/0001628280-26-004327.md) | [81.8](/filings/0001628280-26-027064.md) | [152](/filings/0001628280-26-051294.md) |
| Diluted EPS | $ per share | not reported | [1.63](/filings/0001628280-25-054103.md) | [1.69](/filings/0001628280-25-054103.md) | [1.82](/filings/0001628280-25-054103.md) | not reported | [1.78](/filings/0001628280-26-004327.md) | [1.71](/filings/0001628280-26-027064.md) | [1.83](/filings/0001628280-26-051294.md) | not reported | [2.46](/filings/0001628280-26-004327.md) | [2.55](/filings/0001628280-26-027064.md) | [4.74](/filings/0001628280-26-051294.md) |
| Basic EPS | $ per share | not reported | [1.65](/filings/0001628280-25-054103.md) | [1.71](/filings/0001628280-25-054103.md) | [1.85](/filings/0001628280-25-054103.md) | not reported | [1.80](/filings/0001628280-26-004327.md) | [1.73](/filings/0001628280-26-027064.md) | [1.86](/filings/0001628280-26-051294.md) | not reported | [2.49](/filings/0001628280-26-004327.md) | [2.58](/filings/0001628280-26-027064.md) | [4.80](/filings/0001628280-26-051294.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [69.0](/filings/0001628280-25-054103.md) | [126](/filings/0001628280-25-054103.md) | [59.1](/filings/0001628280-25-054103.md) | [50.6](/filings/0001628280-25-054103.md) | [61.7](/filings/0001628280-25-054103.md) | [73.4](/filings/0001628280-25-054103.md) | [62.1](/filings/0001628280-25-054103.md) | [58.2](/filings/0001628280-25-054103.md) | [62.0](/filings/0001628280-26-051294.md) | [73.4](/filings/0001628280-26-004327.md) | [308](/filings/0001628280-26-027064.md) | [66.8](/filings/0001628280-26-051294.md) |
| Current assets | $m | [1,934](/filings/0001628280-25-054103.md) | [2,095](/filings/0001628280-25-054103.md) | [2,136](/filings/0001628280-25-054103.md) | [2,151](/filings/0001628280-25-054103.md) | [2,123](/filings/0001628280-25-054103.md) | [2,231](/filings/0001628280-25-054103.md) | [2,316](/filings/0001628280-25-054103.md) | [2,386](/filings/0001628280-25-054103.md) | [2,370](/filings/0001628280-26-051294.md) | [2,450](/filings/0001628280-26-004327.md) | [2,794](/filings/0001628280-26-027064.md) | [2,603](/filings/0001628280-26-051294.md) |
| Total assets | $m | [3,768](/filings/0001628280-25-054103.md) | [3,980](/filings/0001628280-25-054103.md) | [4,042](/filings/0001628280-25-054103.md) | [4,080](/filings/0001628280-25-054103.md) | [4,078](/filings/0001628280-25-054103.md) | [4,182](/filings/0001628280-25-054103.md) | [4,307](/filings/0001628280-25-054103.md) | [4,384](/filings/0001628280-25-054103.md) | [4,426](/filings/0001628280-26-051294.md) | [4,552](/filings/0001628280-26-004327.md) | [4,903](/filings/0001628280-26-027064.md) | [4,771](/filings/0001628280-26-051294.md) |
| Current liabilities | $m | [958](/filings/0001628280-25-054103.md) | [1,028](/filings/0001628280-25-054103.md) | [1,032](/filings/0001628280-25-054103.md) | [1,013](/filings/0001628280-25-054103.md) | [1,013](/filings/0001628280-25-054103.md) | [931](/filings/0001628280-25-054103.md) | [969](/filings/0001628280-25-054103.md) | [1,007](/filings/0001628280-25-054103.md) | [1,119](/filings/0001628280-26-051294.md) | [1,053](/filings/0001628280-26-004327.md) | [1,666](/filings/0001628280-26-027064.md) | [1,247](/filings/0001628280-26-051294.md) |
| Total liabilities | $m | [2,167](/filings/0001628280-25-054103.md) | [2,303](/filings/0001628280-25-054103.md) | [2,323](/filings/0001628280-25-054103.md) | [2,319](/filings/0001628280-25-054103.md) | [2,249](/filings/0001628280-25-054103.md) | [2,395](/filings/0001628280-25-054103.md) | [2,501](/filings/0001628280-25-054103.md) | [2,471](/filings/0001628280-25-054103.md) | [2,434](/filings/0001628280-26-051294.md) | [2,486](/filings/0001628280-26-004327.md) | [2,800](/filings/0001628280-26-027064.md) | [2,549](/filings/0001628280-26-051294.md) |
| Long-term debt | $m | [863](/filings/0001628280-25-054103.md) | [920](/filings/0001628280-25-054103.md) | [949](/filings/0001628280-25-054103.md) | [958](/filings/0001628280-25-054103.md) | [874](/filings/0001628280-25-054103.md) | [1,104](/filings/0001628280-25-054103.md) | [1,166](/filings/0001628280-25-054103.md) | [1,082](/filings/0001628280-25-054103.md) | [944](/filings/0001628280-26-051294.md) | [1,052](/filings/0001628280-26-004327.md) | [740](/filings/0001628280-26-027064.md) | [906](/filings/0001628280-26-051294.md) |
| Current portion of debt | $m | [0.0](/filings/0000067887-23-000115.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-25-054103.md) | not reported | not reported | not reported | [1.6](/filings/0001628280-26-051294.md) | [4.7](/filings/0001628280-26-004327.md) | [500](/filings/0001628280-26-027064.md) | [1.6](/filings/0001628280-26-051294.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,602](/filings/0001628280-25-054103.md) | [1,678](/filings/0001628280-25-054103.md) | [1,718](/filings/0001628280-25-054103.md) | [1,762](/filings/0001628280-25-054103.md) | [1,829](/filings/0001628280-25-054103.md) | [1,787](/filings/0001628280-26-004327.md) | [1,806](/filings/0001628280-26-027064.md) | [1,913](/filings/0001628280-26-051294.md) | [1,993](/filings/0001628280-26-051294.md) | [2,066](/filings/0001628280-26-004327.md) | [2,102](/filings/0001628280-26-027064.md) | [2,222](/filings/0001628280-26-051294.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [157 d](/filings/0001628280-25-054103.md) | [61.9](/filings/0001628280-25-054103.md) | [(42.8) d](/filings/0001628280-25-054103.md) | [31.3 d](/filings/0001628280-25-054103.md) | [147 d](/filings/0001628280-25-054103.md) | [(133)](/filings/0001628280-26-004327.md) | [40.0 d](/filings/0001628280-26-027064.md) | [125 d](/filings/0001628280-26-051294.md) | [241 d](/filings/0001628280-25-054103.md) | [(44.8)](/filings/0001628280-26-004327.md) | [130 d](/filings/0001628280-26-027064.md) | [160 d](/filings/0001628280-26-051294.md) |
| Capital expenditure | $m | [52.2 d](/filings/0001628280-25-054103.md) | [39.1](/filings/0001628280-25-054103.md) | [41.5 d](/filings/0001628280-25-054103.md) | [33.3 d](/filings/0001628280-25-054103.md) | [38.2 d](/filings/0001628280-25-054103.md) | [32.8](/filings/0001628280-26-004327.md) | [37.6 d](/filings/0001628280-26-027064.md) | [32.7 d](/filings/0001628280-26-051294.md) | [41.7 d](/filings/0001628280-25-054103.md) | [34.4](/filings/0001628280-26-004327.md) | [31.8 d](/filings/0001628280-26-027064.md) | [27.5 d](/filings/0001628280-26-051294.md) |
| Dividends paid | $m | [8.6 d](/filings/0001628280-25-054103.md) | [8.6](/filings/0001628280-25-054103.md) | [9.0 d](/filings/0001628280-25-054103.md) | [8.9 d](/filings/0001628280-25-054103.md) | [9.0 d](/filings/0001628280-25-054103.md) | [9.0](/filings/0001628280-26-004327.md) | [9.1 d](/filings/0001628280-26-027064.md) | [9.1 d](/filings/0001628280-26-051294.md) | [9.2 d](/filings/0001628280-25-054103.md) | [9.2](/filings/0001628280-26-004327.md) | [9.5 d](/filings/0001628280-26-027064.md) | [9.5 d](/filings/0001628280-26-051294.md) |
| Share repurchases | $m | [6.2 d](/filings/0001628280-25-054103.md) | [8.7](/filings/0001628280-25-054103.md) | [11.5 d](/filings/0001628280-25-054103.md) | [1.6 d](/filings/0001628280-25-054103.md) | [14.9 d](/filings/0001628280-25-054103.md) | [55.7](/filings/0001628280-26-004327.md) | [70.7 d](/filings/0001628280-26-027064.md) | [1.4 d](/filings/0001628280-26-051294.md) | [14.9 d](/filings/0001628280-25-054103.md) | [37.8](/filings/0001628280-26-004327.md) | [12.6 d](/filings/0001628280-26-027064.md) | [12.2 d](/filings/0001628280-26-051294.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.9](/filings/0000067887-24-000010.md) | [32.0](/filings/0000067887-24-000029.md) | [32.1](/filings/0000067887-24-000061.md) | [32.2](/filings/0000067887-25-000010.md) | [32.3](/filings/0000067887-25-000036.md) | [32.4](/filings/0000067887-25-000051.md) | [32.4](/filings/0001628280-26-004327.md) | [31.9](/filings/0001628280-26-027064.md) | [31.9](/filings/0001628280-26-051294.md) | [32.0](/filings/0001628280-26-004327.md) | [32.1](/filings/0001628280-26-027064.md) | [32.1](/filings/0001628280-26-051294.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.